Proteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70

References

• Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005; 10:86 - 103; http://dx.doi.org/10.1379/CSC-99r.1; PMID: 16038406
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 2006; 31:164 - 72; http://dx.doi.org/10.1016/j.tibs.2006.01.006; PMID: 16483782
   PubMed Web of Science ®Google Scholar
• Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, et al. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A 2011; 108:18378 - 83; http://dx.doi.org/10.1073/pnas.1115031108; PMID: 22042860
   PubMed Web of Science ®Google Scholar
• Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007; 130:1005 - 18; http://dx.doi.org/10.1016/j.cell.2007.07.020; PMID: 17889646
   PubMed Web of Science ®Google Scholar
• Min J-N, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 2007; 26:5086 - 97; http://dx.doi.org/10.1038/sj.onc.1210317; PMID: 17310987
   PubMed Web of Science ®Google Scholar
• Meng L, Gabai VL, Sherman MY. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 2010; 29:5204 - 13; http://dx.doi.org/10.1038/onc.2010.277; PMID: 20622894
   PubMed Web of Science ®Google Scholar
• Gabai VL, Meng L, Kim G, Mills TA, Benjamin IJ, Sherman MY. Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. Mol Cell Biol 2012; 32:929 - 40; http://dx.doi.org/10.1128/MCB.05921-11; PMID: 22215620
   PubMed Web of Science ®Google Scholar
• Dudeja V, Chugh RK, Sangwan V, Skube SJ, Mujumdar NR, Antonoff MB, Dawra RK, Vickers SM, Saluja AK. Prosurvival role of heat shock factor 1 in the pathogenesis of pancreatobiliary tumors. Am J Physiol Gastrointest Liver Physiol 2011; 300:G948 - 55; http://dx.doi.org/10.1152/ajpgi.00346.2010; PMID: 21330448
   PubMed Web of Science ®Google Scholar
• Xi C, Hu Y, Buckhaults P, Moskophidis D, Mivechi NF. Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis. J Biol Chem 2012; 287:35646 - 57; http://dx.doi.org/10.1074/jbc.M112.377481; PMID: 22847003
   PubMed Web of Science ®Google Scholar
• Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 2011; 30:2836 - 45; http://dx.doi.org/10.1038/onc.2011.5; PMID: 21297664
   PubMed Web of Science ®Google Scholar
• Gabai VL, Yaglom JA, Waldman T, Sherman MY. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 2009; 29:559 - 69; http://dx.doi.org/10.1128/MCB.01041-08; PMID: 19001088
   PubMed Web of Science ®Google Scholar
• Yaglom JA, Gabai VL, Sherman MY. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 2007; 67:2373 - 81; http://dx.doi.org/10.1158/0008-5472.CAN-06-3796; PMID: 17332370
   PubMed Web of Science ®Google Scholar
• Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009; 136:823 - 37; http://dx.doi.org/10.1016/j.cell.2009.02.024; PMID: 19269363
   PubMed Web of Science ®Google Scholar
• Solimini NL, Luo J, Elledge SJ. Non-oncogene addiction and the stress phenotype of cancer cells. Cell 2007; 130:986 - 8; http://dx.doi.org/10.1016/j.cell.2007.09.007; PMID: 17889643
   PubMed Web of Science ®Google Scholar
• Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007; 317:916 - 24; http://dx.doi.org/10.1126/science.1142210; PMID: 17702937
   PubMed Web of Science ®Google Scholar
• Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, Sanderson BW, Hattem GL, Li R. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 2010; 468:321 - 5; http://dx.doi.org/10.1038/nature09529; PMID: 20962780
   PubMed Web of Science ®Google Scholar
• Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, Gygi SP, Dunham MJ, Amon A. Identification of aneuploidy-tolerating mutations. Cell 2010; 143:71 - 83; http://dx.doi.org/10.1016/j.cell.2010.08.038; PMID: 20850176
   PubMed Web of Science ®Google Scholar
• Tang YC, Williams BR, Siegel JJ, Amon A. Identification of aneuploidy-selective antiproliferation compounds. Cell 2011; 144:499 - 512; http://dx.doi.org/10.1016/j.cell.2011.01.017; PMID: 21315436
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, An WG, Lee JT, Romanova LY, McCubrey JA, Blagosklonny MV. Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin. Cancer Biol Ther 2005; 4:484 - 90; http://dx.doi.org/10.4161/cbt.4.4.1702; PMID: 15846067
   PubMed Web of Science ®Google Scholar
• O’Callaghan-Sunol C, Gabai VL, Sherman MY. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 2007; 67:11779 - 88; http://dx.doi.org/10.1158/0008-5472.CAN-07-2441; PMID: 18089808
   PubMed Web of Science ®Google Scholar
• Yaglom JA, Gabai VL, Meriin AB, Mosser DD, Sherman MY. The function of HSP72 in suppression of c-Jun N-terminal kinase activation can be dissociated from its role in prevention of protein damage. J Biol Chem 1999; 274:20223 - 8; http://dx.doi.org/10.1074/jbc.274.29.20223; PMID: 10400639
   PubMed Web of Science ®Google Scholar
• Yaglom J, O’Callaghan-Sunol C, Gabai V, Sherman MY. Inactivation of dual-specificity phosphatases is involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp72. Mol Cell Biol 2003; 23:3813 - 24; http://dx.doi.org/10.1128/MCB.23.11.3813-3824.2003; PMID: 12748284
   PubMed Web of Science ®Google Scholar
• Rérole AL, Gobbo J, De Thonel A, Schmitt E, Pais de Barros JP, Hammann A, Lanneau D, Fourmaux E, Deminov O, Micheau O, et al. Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Res 2011; 71:484 - 95; http://dx.doi.org/10.1158/0008-5472.CAN-10-1443; PMID: 21224349
   PubMed Web of Science ®Google Scholar
• Neznanov N, Komarov AP, Neznanova L, Stanhope-Baker P, Gudkov AV. Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2011; 2:209 - 21; PMID: 21444945
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ 2006; 13:1434 - 41; http://dx.doi.org/10.1038/sj.cdd.4401812; PMID: 16311509
   PubMed Web of Science ®Google Scholar
• Yerlikaya A, Okur E, Eker S, Erin N. Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line. Mol Med Rep 2010; 3:333 - 9; http://dx.doi.org/10.3892/mmr_000000262; PMID: 21472244
   PubMed Web of Science ®Google Scholar
• Kim G, Meriin AB, Gabai VL, Christians E, Benjamin I, Wilson A, Wolozin B, Sherman MY. The heat shock transcription factor Hsf1 is downregulated in DNA damage-associated senescence, contributing to the maintenance of senescence phenotype. Aging Cell 2012; 11:617 - 27; http://dx.doi.org/10.1111/j.1474-9726.2012.00827.x; PMID: 22510478
   PubMed Web of Science ®Google Scholar
• Zaarur N, Gabai VL, Porco JA Jr., Calderwood S, Sherman MY. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res 2006; 66:1783 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-05-3692; PMID: 16452239
   PubMed Web of Science ®Google Scholar